Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1731 Demethoxyviridin
Potent inhibitor of PI3 kinases
More description
DCC1730 Delta-tocopherol
Vitamin E variant, inhibiting prostate adenocarcinoma, lung tumorigenesis, promoting thermogenic gene expression via PGC-1α upregulation, preventing methylglyoxal-induced apoptosis by reducing ROS generation and inhibiting apoptotic signaling cascades
More description
DCC1729 Delcasertib
Novel selective δ-protein kinase C inhibitor
More description
DCC1728 Dehydrorabelomycin
Natural polyketide matabolite
More description
DCC1727 Degrader Bt1
Novel selective degrader of BCR-ABL over c-ABL in leukemia cancer cells
More description
DCC1726 Deferoxamine Hydrochloride
Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile
More description
DCC1725 Deferasirox Ferrate(iii) Tripotassium Complex
Deferasirox iron complex
More description
DCC1724 Debio-1452-nh3
Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli
More description
DCC1723 Deac-pda-atp
Fluorophore to myosin or actomyosin
More description
DCC1722 Deacm-caged D-luciferin
Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm
More description
DCC1721 Dea Nonoate Sodium Salt
NO donor, generating a controlled release of nitric oxide in solution.
More description
DCC1720 Ddr-trk-1n
Negative control for DDR-TRK-1
More description
DCC1719 Ddri-18
Inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin
More description
DCC1718 Ddr1-in-2
Potent and selective DDR1 receptor tyrosine kinase inhibitor
More description
DCC1717 ddpm-1457
Potent mGAT4 inhibitor
More description
DCC1716 Ddo-7204
Novel Nrf2 activator
More description
DCC1715 Ddo-7132
Novel NQO1 substrate, inhibiting cancer cell (NQO1-rich A549 cell line) growth
More description
DCC1714 Ddo-2213
Novel Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 (MLL1) Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia
More description
DCC1713 Ddo-2117
Novel potent blocker of mixed lineage leukemia 1 (MLL1)-WDR5 interaction, inhibiting MLL1 complex H3K4 methyltransferase activity
More description
DCC1712 Ddhctp Sodium Salt
Novel potent and broad-spectrum antiviral agent, acting as a chain terminator for viral RNA polymerase
More description
DCC1711 Ddd100097
Potent inhibitor of Trypanosoma brucei N-myristoyltransferase (TbNMT) with markedly improved blood-brain barrier permeability
More description
DCC1710 Ddd-028
Potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain
More description
DCC1709 Ddd01035881
Novel transmission blocker of antimalarials, targeting male gametes
More description
DCC1708 Ddd00015314
Novel activator of the GUS reporter activity, specific increasing in stumpy reporter gene expression
More description
DCC1707 Ddc4002
First-generation allosteric EGFR inhibitor, binding to the allosteric site of EGFR along with ATP that leads to inhibition of cell proliferation and arrest of EGFR L858R/T790M/C797S signalling
More description
DCC1705 Dd-04-015
Novel selective BTK degrader, demonstrating prolonged pharmacodynamic effects
More description
DCC1704 Dcz3112
Novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction
More description
DCC1703 Dc-teadin02
Novel potent and selective TEAD autopalmitoylation inhibitor, inhibiting TEADs transcription activity and downstream gene expression
More description
DCC1702 Dc-s239
Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor
More description
DCC1701 Dc-s238
Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X